Despite large investments in and policy support for harm reduction including naloxone, sy-
ringes, and medications for opioid use disorder, people who use drugs continue to experience unprecedented rates of mortality from overdose and morbidity from infectious diseases. The
criminalization of drug use has disproportionately exacerbated these drug-related harms and
imposed short- and long-term burdens on already marginalized and vulnerable populations.